X0508 4 2026-01-05 0001880438 AN2 Therapeutics, Inc. ANTX 0001914510 Day Lucy C/O AN2 THERAPEUTICS, INC. 1300 EL CAMINO REAL, SUITE 100 MENLO PARK CA 94025 false true false false Chief Financial Officer false Common Stock 2026-01-05 4 S false 3295 1.003 D 80875 D Common Stock 2026-01-06 4 S false 5512 1.012 D 75363 D Represents shares sold pursuant to the terms of the grant to satisfy tax withholding obligations arising from the vesting of Restricted Stock Units ("RSUs") on January 1, 2026. Includes (a) 27,500 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from January 1, 2024 and (b) 46,500 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from January 1, 2025, in each case subject to the Reporting Person continuing to provide services to the Company as an employee, consultant or director of the Company through each applicable vesting date. Reflects the adjusted total which includes the purchase of 5,000 shares under the Issuer's Employee Stock Purchase Plan on September 30, 2025. /s/ Lucy Day 2026-01-07